.../HCV 合并感染以及两种病毒均未感染;观察结果包括蛋白尿( >1+ )、评估的肾小球滤过率( estimated glomerular filtration rate , eGFR )降低( <60 mL/min/1.73 m2 )和慢性肾病( chronic kidney dise..
基于2个网页-相关网页
初级评估疗效指标是肾小球过滤率的变化,观察在18个月和36个月(3年)的肾小球滤过率(GFR)变化。
The primary outcome measure was progression of nephropathy, which was assessed by change in glomerular filtration rate (GFR) at 18 and 36 months.
胱抑素c是一种小分子量分泌性蛋白质,一直是评估肾小球滤过率的标示物。
Cystatin c, a small molecular weight secreted protein, is a marker for evaluating glomerular filtration.
应用推荐